{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:49:26Z","timestamp":1770986966529,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2172,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jpainsymman.2013.03.012","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T11:51:22Z","timestamp":1373629882000},"page":"334-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Qutaiba A.","family":"Tawfic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S.","family":"Faris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajini","family":"Kausalya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2013.03.012_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.hoc.2005.07.008","article-title":"Pain management of sickle cell disease","volume":"19","author":"Ballas","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/03630269.2011.610478","article-title":"Update on pain management in sickle cell disease","volume":"35","author":"Ballas","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1526-4637.2009.00601.x","article-title":"Pain syndromes in sickle cell disease: an update","volume":"10","author":"Niscola","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jpepsy\/16.5.643","article-title":"Sickle cell disease in children and adolescents: the relation of child and parent pain coping strategies to adjustment","volume":"16","author":"Gil","year":"1991","journal-title":"J\u00a0Pediatr Psychol"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib5","first-page":"107","article-title":"Effect of alpha-globin genotype on the pathophysiology of sickle cell disease","volume":"20","author":"Ballas","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1076029609352661","article-title":"Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion","volume":"16","author":"Mousa","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib7","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1542\/peds.2010-3686","article-title":"Management of children with sickle cell disease: a comprehensive review of the literature","volume":"128","author":"Kavanagh","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib8","first-page":"CD003350","article-title":"Pain management for sickle cell disease","volume":"2","author":"Dunlop","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/erp.09.32","article-title":"Pain management and quality of life in sickle cell disease","volume":"9","author":"Howard","year":"2009","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/asheducation-2007.1.97","article-title":"Current issues in sickle cell pain and its management","author":"Ballas","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpainsymman.2010.03.020","article-title":"Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home","volume":"40","author":"Ballas","year":"2010","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SPC.0b013e328339429a","article-title":"The management of painful crisis in sickle cell disease","volume":"4","author":"Wright","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pbc.20403","article-title":"Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome","volume":"45","author":"Buchanan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ajh.20944","article-title":"Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial","volume":"82","author":"van Beers","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.anclin.2011.04.009","article-title":"Challenges in acute pain management","volume":"29","author":"Gandhi","year":"2011","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1213\/00000539-199907000-00017","article-title":"Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery","volume":"89","author":"Suzuki","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","article-title":"Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series","volume":"26","author":"Zempsky","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1213\/01.ANE.0000118109.12855.07","article-title":"Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review","volume":"99","author":"Subramaniam","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib19","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jpainsymman.2011.06.003","article-title":"Ketamine infusion for sickle cell crisis pain in an adult","volume":"42","author":"Meals","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pain.2004.09.036","article-title":"Ketamine and postoperative pain\u2014a quantitative systematic review of randomised trials","volume":"113","author":"Elia","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib21","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/00000539-200111000-00023","article-title":"The use of midazolam and small-dose ketamine for sedation and analgesia during local anesthesia","volume":"93","author":"Deng","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib22","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1111\/j.1651-2227.2011.02311.x","article-title":"Comparison of a morphine and midazolam combination with morphine alone for paediatric displaced fractures: a randomized study","volume":"100","author":"Wille-Ledon","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib23","first-page":"1001","article-title":"Use of midazolam and ketamine as sedation for children undergoing minor operative procedures","volume":"13","author":"Cheuk","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2013.03.012_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1553-2712.2007.00022.x","article-title":"Safety and clinical effectiveness of midazolam versus propofol for procedural sedation in the emergency department: a systematic review","volume":"15","author":"Hohl","year":"2008","journal-title":"Acad Emerg Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392413002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392413002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:11:32Z","timestamp":1760130692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392413002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0885392413002686"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.03.012","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}